OTTAWA, Ontario, April 29, 2016 -- This year's National Hospice Palliative Care Week is entitled "Hospice Palliative Care First" and encourages Canadians to advocate for quality hospice palliative care at their local levels. The Canadian Hospice Palliative Care Association (CHPCA), which organizes the campaign every year, hopes that individuals will use the resources developed this year to act as champions for end-of-life care in Canada by sharing and distributing them within their communities.
The CHPCA's principle behind this campaign is the hope that education and awareness of hospice palliative care nation-wide will encourage federal and provincial leadership in providing more support for the care that aging Canadians need. The organization is encouraging individuals to partake in advocacy through certain activities including: speaking out to the media, meeting with provincial and federal representatives, and promoting resources from the Speak Up: Advance Care Planning (ACP) campaign.
"The more we can encourage people at the local level to champion for hospice palliative care, the louder our collective voices will be," said Sharon Baxter, Executive Director of the Canadian Hospice Palliative Care Association. "People at all ages can get involved in this campaign simply by starting the conversation about end-of-life care and by sharing resources on our website and in the kits."
For this year's campaign, the CHPCA has released a bilingual call-to-action poster listing ways that people can get involved and make difference. Also included is a "myth-buster" poster, intended to clarify facts about hospice palliative care, and an F.A.Q. poster directed towards physicians about end-of-life care.
"This campaign is a call-to-action for all Canadians, including caregivers, physicians and political leaders in the name of hospice palliative care."
National Hospice Palliative Care Week is coordinated by the Canadian Hospice Palliative Care Association. Funding for National Hospice Palliative Care Week is provided by Purdue, Innovative Medicines Canada, and GlaxoSmithKline. For more information, and promotional materials for National Hospice Palliative Care Week, please go to www.chpca.net/week.
The Canadian Hospice Palliative Care Association -- the national voice for hospice palliative care in Canada – is dedicated to the pursuit of excellence in care for persons approaching death so that the burdens of suffering, loneliness and grief are lessened. The CHPCA operates in close partnership with other national organizations and continues to work to ensure that all Canadians, regardless of where they may live, have equal access to quality hospice palliative care services for themselves and their family.
CONTACT: Sarah Levesque
Communications Officer
CHPCA
1-800-668-2785, x 229
[email protected]


Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 



